4021:TSENissan Chemical Corporation Analysis
Data as of 2026-06-17 - not real-time
¥7,925.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Nissan Chemical’s share price is trading near its recent high and remains comfortably above both the short‑term and medium‑term moving averages, signalling continued bullish momentum. The RSI is elevated but not yet in the extreme overbought zone, while the MACD line stays above its signal, reinforcing the upside bias. Volume, however, has been on a downtrend, which could temper short‑term enthusiasm. The stock’s beta is low, indicating muted sensitivity to broader market swings, yet 30‑day volatility is relatively high, suggesting price swings may still be pronounced. Fundamentally, the company delivers solid margins, strong cash generation and an attractive dividend yield that comfortably covers its payout ratio. A discounted cash flow model places intrinsic value below the current market level, and the upside‑downside metric is negative, pointing to a potential overvaluation. The fear‑and‑greed index is in the extreme greed zone, reflecting heightened market optimism. Analyst consensus leans toward a buy recommendation, but price appreciation may be limited in the near term. Overall, the blend of bullish technicals, robust fundamentals, and valuation concerns creates a nuanced picture that warrants careful positioning.
Investors should weigh the strong dividend sustainability and low systematic risk against the elevated valuation and waning volume. The sector’s exposure to commodity cycles and regulatory scrutiny adds a moderate layer of risk, while the company’s diversified product portfolio and international presence help mitigate geographic concentration. In this context, a cautious but optimistic stance is advisable, with a focus on medium‑ to long‑term horizons.
Investors should weigh the strong dividend sustainability and low systematic risk against the elevated valuation and waning volume. The sector’s exposure to commodity cycles and regulatory scrutiny adds a moderate layer of risk, while the company’s diversified product portfolio and international presence help mitigate geographic concentration. In this context, a cautious but optimistic stance is advisable, with a focus on medium‑ to long‑term horizons.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish technical alignment with moving averages and MACD
- Elevated valuation relative to discounted cash flow
- Decreasing volume trend
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong cash flow generation and dividend sustainability
- Stable earnings margins and solid ROE
- Analyst consensus favoring the stock
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Low beta and defensive risk profile
- Diversified product portfolio across chemicals and specialty materials
- Consistent dividend payout supported by free cash flow
Key Metrics & Analysis
Financial Health
Revenue Growth10.00%
Profit Margin17.78%
P/E Ratio21.5
ROE20.39%
ROA11.58%
Debt/Equity14.84
P/B Ratio4.2
Op. Cash Flow¥64.2B
Free Cash Flow¥32.5B
Technical Analysis
TrendBullish
RSI69.8
Support¥6,968.00
Resistance¥7,942.00
MA 20¥7,415.95
MA 50¥6,999.24
MA 200¥5,944.47
MACDBullish
VolumeDecreasing
Fear & Greed Index88.5
Valuation
Fair Value¥4,890.52
Target Price¥7,500.00
Upside/Downside-5.36%
GradeOvervalued
TypeBlend
Dividend Yield2.72%
Risk Assessment
Beta0.33
Volatility28.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.